Format

Send to

Choose Destination
J Virus Erad. 2018 Nov 15;4(Suppl 2):26-32.

Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities.

Author information

1
Division of Epidemiology, College of Public Health, Ohio State University, Columbus, OH, USA.
2
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
3
SEARCH, Thai Red Cross AIDS Research Center,  Bangkok, Thailand.
4
Retrovirus Research Center, Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico.
5
Department of Maternal and Child Health, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, NC, USA.
6
Department of Anthropology, University of California, Riverside, CA, USA.

Abstract

As universal testing and treatment for HIV, or 'treat all', expands across sub-Saharan Africa (SSA), substance use will likely have a negative impact on the success of scale-up efforts for antiretroviral treatment (ART). Overwhelming evidence highlights the negative impact of substance use on HIV care and treatment outcomes. Yet, as many countries in SSA expand ART, evidence of the extent of substance use, and its impact in the region, is more limited. Stigma, and the psychoactive effects of substance use, are barriers to seeking HIV treatment and adhering to ART regimens for persons with heavy alcohol use or substance use. As a result, we identified several implementation and operations research priorities and metrics for monitoring the impact of substance use and Treat All. Identifying barriers and facilitators to the integration of the prevention and treatment of substance use with HIV care, and assessing effects on HIV outcomes, through longitudinal studies are priorities that will determine the impacts of substance use on 'treat all' in SSA. Future research must use existing infrastructure, including large networks of HIV clinics, to enhance our understanding of the implementation and service delivery of substance use screening, referral and treatment. These networks will also inform robust and standardised substance use estimates and interventions within the 'treat all' era in SSA.

KEYWORDS:

injection drug use, non-injection drug use, alcohol, antiretroviral treatment, Africa

PMID:
30515311
PMCID:
PMC6248849

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center